natgillin/translations-raw huggingface dataset:
After removing NovoMix 70 Penfill or NovoMix 70 FlexPen from the refrigerator, it is recommended to allow NovoMix 70 Penfill or NovoMix 70 FlexPen to reach room temperature before resuspending the insulin as instructed for first time use. 
6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Potem ko zdravilo NovoMix 70 Penfill ali zdravilo NovoMix 70 FlexPen vzamete iz hladilnika, je zdravilo NovoMix 70 Penfill ali zdravilo NovoMix 70 FlexPen priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate, kot opisujejo navodila za prvo uporabo.
The insulin aspart in the soluble phase of NovoMix 70 comprises 70% of the total insulin; this is absorbed more rapidly from the subcutaneous layer than the soluble insulin component of biphasic human insulin. 
Insulin aspart v topni fazi zdravila NovoMix 70 obsega 70 % celotnega insulina; ta se iz podkožja absorbira hitreje kot topna insulinska komponenta dvofaznega humanega insulina.
However, the NovoMix 30 dose may need to be adjusted. 
Lahko pa je potrebna prilagoditev odmerka zdravila NovoMix 30.
Since NovoMix 50 should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected. 
Ker je treba zdravilo NovoMix 50 aplicirati neposredno ob obroku, je treba pri bolnikih s sočasnimi boleznimi ali zdravljenjem, pri katerih lahko pričakujemo upočasnjeno absorpcijo hrane, upoštevati hiter začetek delovanja zdravila .
Always use the dose selector and the pointer to see how many units you have selected before injecting the insulin. 
Pred injiciranjem insulina z izbirnikom odmerka in kazalnikom vedno preverite, koliko enot ste izbrali.
When necessary, NovoMix 70 can be given soon after a meal. 
Če je potrebno, je zdravilo NovoMix 70 mogoče dati kmalu po obroku.
NovoMix 70 is not to be used in insulin infusion pumps. 
Zdravila NovoMix 70 se ne sme uporabljati v infuzijskih črpalkah za insulin.
Important information about some of the ingredients in NovoMix 70 
Pomembne informacije o nekaterih sestavinah zdravila NovoMix 70
What NovoMix 50 looks like and contents of the pack 
Izgled zdravila NovoMix 50 in vsebina pakiranja
NovoMix 70 will start to lower your blood sugar 10-20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 14-24 hours. 
Zdravilo NovoMix 70 začne sladkor v krvi zniževati v 10 do 20 minutah po injiciranju, doseže največji učinek v 1 do 4 urah po injiciranju in deluje med 14 in 24 ur.
Other medicines and NovoMix 50 
Druga zdravila in zdravilo NovoMix 50
Dispose of the used FlexPen carefully without the needle attached. 
Odrabljeni injekcijski peresnik FlexPen pazljivo zavrzite; pazite, da boste pred tem z njega odstranili iglo.
After removing NovoMix 50 Penfill or NovoMix 50 FlexPen from the refrigerator, it is recommended to allow NovoMix 50 Penfill or NovoMix 50 FlexPen to reach room temperature before resuspending the insulin as instructed for first time use. 
6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Potem ko zdravilo NovoMix 50 Penfill ali NovoMix 50 FlexPen vzamete iz hladilnika, je zdravilo NovoMix 50 Penfill ali NovoMix 50 FlexPen priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate, kot opisujejo navodila za prvo uporabo.
In healthy volunteers, a mean maximum serum concentration of 140 ± 32 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.20 unit/kg body weight. 
Pri zdravih prostovoljcih je bila največja koncentracija v serumu 140 ± 32 pmol/l dosežena okrog 60 minut po subkutanem odmerku 0,20 enote/kg telesne mase.
► If the resuspended insulin does not appear uniformly white, cloudy and aqueous. 
► če suspenzija insulina ni enakomerno bela, motna in vodna,
Other medicines and NovoMix 30 
Druga zdravila in zdravilo NovoMix 30
There is limited clinical experience with NovoMix 70 in pregnancy. 
Klinične izkušnje z zdravilom NovoMix 70 med nosečnostjo so omejene.
Before using NovoMix 50 
Preden uporabite zdravilo NovoMix 50
NovoMix 30 is generally taken immediately before a meal. 
Zdravilo NovoMix 30 se praviloma uporabi tik pred obrokom.
NovoMix 30 will start to lower your blood sugar 10-20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 24 hours. 
Zdravilo NovoMix 30 začne sladkor v krvi zniževati v 10 do 20 minutah po injiciranju, doseže največji učinek v 1 do 4 urah po injiciranju in deluje do 24 ur.
► If you are treated with NovoMix 50 Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin. 
► Če se zdravite z zdravilom NovoMix 50 Penfill in še drugim insulinom v vložkih Penfill, morate za vsako vrsto insulina uporabiti svoj sistem za dajanje insulina.
NovoMix 70 has a faster onset of action than biphasic human insulin and should generally be given immediately before a meal. 
Zdravilo NovoMix 70 ima hitrejši začetek delovanja kot dvofazni humani insulin in ga je praviloma treba aplicirati tik pred obrokom.
The insulin aspart in the soluble phase of NovoMix 50 comprises 50% of the total insulin; this is absorbed more rapidly from the subcutaneous layer than the soluble insulin component of biphasic human insulin. 
Insulin aspart v topni fazi zdravila NovoMix 50 obsega 50 % celotnega insulina; ta se iz podkožja absorbira hitreje kot topna insulinska komponenta dvofaznega humanega insulina.
Animal reproduction studies have not revealed any differences between insulin aspart and human insulin regarding fertility. 
Plodnost Kar zadeva plodnost, študije reprodukcije na živalih niso odkrile razlik med insulinom aspart in humanim insulinom.
The suspension contains rapid-acting and intermediate-acting insulin aspart in the ratio 70/30. 
Suspenzija vsebuje hitrodelujoči in srednjedolgodelujoči insulin aspart v razmerju 70/30.
Discard the needle after each injection 
Iglo po vsakem injiciranju zavrzite.
Resuspension of NovoMix 70 
Resuspendiranje zdravila NovoMix 70
Important information about some of the ingredients in NovoMix 30 
Pomembne informacije o nekaterih sestavinah zdravila NovoMix 30
• Drink alcohol (see Drinking alcohol and taking NovoMix 30 in section 2). 
• če pijete alkohol (glejte poglavje 2, podpoglavje Zdravilo NovoMix 30 skupaj z alkoholom).
Since NovoMix 30 should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected. 
Ker je treba zdravilo NovoMix 30 aplicirati neposredno ob obroku, je treba pri bolnikih s sočasnimi boleznimi ali zdravljenjem, pri katerih lahko pričakujemo upočasnjeno absorpcijo hrane, upoštevati hiter začetek delovanja zdravila .
There is limited clinical experience with NovoMix 50 in pregnancy. 
Klinične izkušnje z zdravilom NovoMix 50 med nosečnostjo so omejene.
On rare occasions, injection site reactions may require discontinuation of NovoMix 30. 
V redkih primerih je lahko zaradi reakcij na mestu injiciranja potrebna prekinitev uporabe zdravila NovoMix 30.
The suspension contains rapid-acting and intermediate-acting insulin aspart in the ratio 30/70. 
Suspenzija vsebuje hitrodelujoči in srednjedolgodelujoči insulin aspart v razmerju 30/70.
There is limited clinical experience with NovoMix 30 in pregnancy. 
Klinične izkušnje z zdravilom NovoMix 30 med nosečnostjo so omejene.
► Every time you use a new NovoMix 70 Penfill (before you put the cartridge into the insulin delivery system) 
► Vsakokrat, ko uporabite novo zdravilo NovoMix 70 Penfill (preden vstavite vložek v sistem za dajanje insulina)
How to use NovoMix 50 
Kako uporabljati zdravilo NovoMix 50
The insulin aspart in the soluble phase of NovoMix 30 comprises 30% of the total insulin; this is absorbed more rapidly from the subcutaneous layer than the soluble insulin component of biphasic human insulin. 
Insulin aspart v topni fazi zdravila NovoMix 30 obsega 30 % celotnega insulina; ta se iz podkožja absorbira hitreje kot topna insulinska komponenta dvofaznega humanega insulina.
NovoMix 70 is a biphasic insulin, which contains 70% soluble insulin aspart. 
Zdravilo NovoMix 70 je dvofazni insulin, ki vsebuje 70 % topnega insulina aspart.
Blood glucose monitoring and insulin dose adjustments are recommended to achieve optimal glycaemic control. 
Za doseganje optimalne urejenosti glikemije je priporočljivo nadzirati glukozo v krvi in prilagajati odmerek insulina.
SPECIAL STORAGE CONDITIONS Before opening: Store in a refrigerator (2°C to 8°C) During use: Do not refrigerate. 
POSEBNA NAVODILA ZA SHRANJEVANJE Pred odprtjem: shranjujte v hladilniku (2 °C - 8 °C).
NovoMix 50 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 50/50. 
Zdravilo NovoMix 50 je sodobni insulin (insulinski analog), s hitrim in s srednjedolgim delovanjem, v razmerju 50/50.
NovoMix 30 FlexPen EU/1/00/142/009 EU/1/00/142/010 EU/1/00/142/023 EU/1/00/142/024 EU/1/00/142/025 
NovoMix 30 FlexPen EU/1/00/142/009 EU/1/00/142/010 EU/1/00/142/023 EU/1/00/142/024
NovoMix 50 is not to be used in insulin infusion pumps. 
Zdravila NovoMix 50 se ne sme uporabljati v infuzijskih črpalkah za insulin.
What NovoMix 30 looks like and contents of the pack 
Izgled zdravila NovoMix 30 in vsebina pakiranja
4.2, the mean reduction in HbA1c was 2.8% with NovoMix 30 (mean at baseline = 9.7%). 
Po 28 tednih zdravljenja v skladu s smernicami za odmerjanje, opisanimi v poglavju 4.2, je bilo povprečno znižanje HbA1c z zdravilom NovoMix 30 2,8 % (povprečna izhodiščna vrednost je bila 9,7 %).
NovoMix 50 has a faster onset of action than biphasic human insulin and should generally be given immediately before a meal. 
Zdravilo NovoMix 50 ima hitrejši začetek delovanja kot dvofazni humani insulin in ga je praviloma treba aplicirati tik pred obrokom.
Important information about some of the ingredients in NovoMix 50 
Pomembne informacije o nekaterih sestavinah zdravila NovoMix 50
Needle (example) 
NALEPKA (VLOŽEK Penfill)
► Every time you use a new NovoMix 50 Penfill (before you put the cartridge into the insulin delivery system) 
► Vsakokrat, ko uporabite novo zdravilo NovoMix 50 Penfill (preden vstavite vložek v sistem za dajanje insulina)
After removing NovoMix 30 Penfill or NovoMix 30 FlexPen from the refrigerator, it is recommended to allow NovoMix 30 Penfill or NovoMix 30 FlexPen to reach room temperature before resuspending the insulin as instructed for first time use. 
6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Potem ko zdravilo NovoMix 30 Penfill ali zdravilo NovoMix 30 FlexPen vzamete iz hladilnika, je zdravilo NovoMix 30 Penfill ali zdravilo NovoMix 30 FlexPen priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate, kot opisujejo navodila za prvo uporabo.
Resuspension of NovoMix 50 
Resuspendiranje zdravila NovoMix 50
The necessity of resuspending the NovoMix 70 suspension immediately before use is to be stressed to the patient. 
Bolniku je treba posebej poudariti, da je treba suspenzijo NovoMix 70 tik pred uporabo resuspendirati.
When NovoMix 70 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection. 
Če se zdravilo NovoMix 70 injicira subkutano, začne delovati v 10 do 20 minutah.
NovoMix 50 is a mixture consisting of 50% soluble insulin aspart and 50% insulin aspart crystallised with protamine. 
Zdravilo NovoMix 50 je mešanica, ki vsebuje 50 % topnega insulina aspart in 50 % insulina aspart, kristaliziranega s protaminom.
Keep the cartridge in the outer carton in order to protect it from light. 
Vložek shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
► Every time you use a new NovoMix 30 Penfill (before you put the cartridge into the insulin delivery system) 
► Vsakokrat, ko uporabite novo zdravilo NovoMix 30 Penfill (preden vstavite vložek v sistem za dajanje insulina)
Pre-meal blood glucose levels should be used to evaluate the adequacy of the preceding dose. 
Za ocenjevanje ustreznosti prejšnjega odmerka morate uporabiti koncentracijo glukoze v krvi pred obrokom.
NovoMix 30 is a biphasic insulin, which contains 30% soluble insulin aspart. 
Zdravilo NovoMix 30 je dvofazni insulin, ki vsebuje 30 % topnega insulina aspart.
When NovoMix 50 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection. 
Če se zdravilo NovoMix 50 injicira subkutano, začne delovati v 10 do 20 minutah.
When NovoMix 30 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection. 
Če se zdravilo NovoMix 30 injicira subkutano, začne delovati v 10 do 20 minutah.
The necessity of resuspending the NovoMix 30 suspension immediately before use is to be stressed to the patient. 
Bolniku je treba posebej poudariti, da je treba suspenzijo NovoMix 30 tik pred uporabo resuspendirati.
► If you drink alcohol, your need for insulin may change as your blood sugar level may either rise or fall. 
Zdravilo NovoMix 30 skupaj z alkoholom ► Če pijete alkohol, se vam potreba po insulinu lahko spremeni, kajti koncentracija krvnega sladkorja se vam lahko poveča ali zmanjša.
NovoMix 30 has a faster onset of action than biphasic human insulin and should generally be given immediately before a meal. 
Zdravilo NovoMix 30 ima hitrejši začetek delovanja kot dvofazni humani insulin in ga je praviloma treba aplicirati tik pred obrokom.
NovoMix 30 is not to be used in insulin infusion pumps. 
Zdravila NovoMix 30 se ne sme uporabljati v infuzijskih črpalkah za insulin.
The pharmacokinetics of NovoMix 70 have not been investigated in paediatrics, elderly patients or in patients with renal or hepatic impairment. 
Posebne skupine bolnikov Farmakokinetika zdravila NovoMix 70 ni raziskana pri otrocih, starejših bolnikih in bolnikih z okvaro ledvic ali jeter.
In healthy volunteers, a mean maximum serum concentration of 445 ± 135 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.30 unit/kg body weight. 
Pri zdravih prostovoljcih je bila povprečna največja koncentracija v serumu 445 ± 135 pmol/l dosežena okrog 60 minut po subkutanem odmerku 0,30 enote/kg telesne mase.
How to use NovoMix 30 
Kako uporabljati zdravilo NovoMix 30
Insulin treatment of the nursing mother presents no risk to the baby. 
Omejitev za zdravljenje z zdravilom NovoMix 30 med dojenjem ni. Zdravljenje doječe matere z insulinom ne pomeni nobene nevarnosti za dojenčka.
• No data are available for NovoMix 30 in children below 6 years of age. 
• O uporabi zdravila NovoMix 30 pri otrocih, mlajših od 6 let, podatki niso na voljo.
No data are available for NovoMix 30 in children below 6 years of age. 
O uporabi zdravila NovoMix 30 pri otrocih, mlajših od 6 let, podatki niso na voljo.
When necessary, NovoMix 50 can be given soon after a meal. 
Če je potrebno, je zdravilo NovoMix 50 mogoče dati kmalu po obroku.
Pen cap 
pokrovček peresnika
INFORMATION IN BRAILLE NovoMix 50 Penfill 
PODATKI V BRAILLOVI PISAVI NovoMix 50 PenFill
NovoMix 50 is a biphasic insulin, which contains 50% soluble insulin aspart. 
Zdravilo NovoMix 50 je dvofazni insulin, ki vsebuje 50 % topnega insulina aspart.
Resuspension of NovoMix 30 
Resuspendiranje zdravila NovoMix 30
Read the following instructions carefully before using your FlexPen. 
Pred uporabo preberite priloženo navodilo.
When necessary, NovoMix 30 can be given soon after a meal. 
Če je potrebno, je zdravilo NovoMix 30 mogoče dati kmalu po obroku.
• If you get any side effects, talk to your doctor, nurse or pharmacist. 
• Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom, medicinsko sestro ali s farmacevtom.
NovoMix 70 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 70/30. 
Zdravilo NovoMix 70 je sodobni insulin (insulinski analog), s hitrim in s srednjedolgim delovanjem, v razmerju 70/30.
NovoMix 70 is for injection under the skin (subcutaneously). 
Zdravilo NovoMix 70 je namenjeno injiciranju pod kožo (subkutani uporabi).
Renal and hepatic impairment 
Ledvična ali jetrna okvara
NovoMix 50 is a biphasic suspension of 50% soluble insulin aspart (rapid-acting human insulin analogue) and 50% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue). 
Zdravilo NovoMix 50 je dvofazna suspenzija, s 50 % topnega insulina aspart (hitrodelujočega analoga humanega insulina) in 50 % s protaminom kristaliziranega insulina aspart (srednjedolgodelujočega analoga humanega insulina).
NovoMix 30 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 30/70. 
Zdravilo NovoMix 30 je sodobni insulin (insulinski analog), s hitrim in s srednjedolgim delovanjem, v razmerju 30/70.
NovoMix 50 is for injection under the skin (subcutaneously). 
Zdravilo NovoMix 50 je namenjeno injiciranju pod kožo (subkutani uporabi).
NovoMix 50 is presented as a suspension for injection. 
Zdravilo NovoMix 50 je na voljo v obliki suspenzije za injiciranje.
The necessity of resuspending the NovoMix 50 suspension immediately before use is to be stressed to the patient. 
Bolniku je treba posebej poudariti, da je treba suspenzijo NovoMix 50 tik pred uporabo resuspendirati.
In healthy volunteers, a mean maximum serum concentration of 645 ± 185 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.30 unit/kg body weight. 
Pri zdravih prostovoljcih je bila povprečna največja koncentracija v serumu 645 ± 185 pmol/l dosežena okrog 60 minut po subkutanem odmerku 0,30 enote/kg telesne mase.
NovoMix 70 is presented as a suspension for injection. 
Zdravilo NovoMix 70 je na voljo v obliki suspenzije za injiciranje.
The pharmacokinetics of NovoMix 30 have not been investigated in elderly patients or in patients with renal or hepatic impairment. 
Posebne skupine bolnikov Farmakokinetika zdravila NovoMix 30 ni raziskana pri starejših bolnikih in bolnikih z okvaro ledvic ali jeter.
NovoMix 70 is indicated for treatment of diabetes mellitus in adults. 
4.1 Terapevtske indikacije Zdravilo NovoMix 70 je namenjeno zdravljenju sladkorne bolezni pri odraslih.
► After each injection, be sure to remove and discard the needle and store NovoMix 70 without the needle attached. 
► Po vsakem injiciranju morate iglo odstraniti in zavreči, zdravilo NovoMix 70 pa shraniti brez nameščene igle.
INFORMATION IN BRAILLE NovoMix 50 FlexPen 
PODATKI V BRAILLOVI PISAVI NovoMix 50 FlexPen
GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subject to medical prescription 
Imetnik dovoljenja za promet z zdravilom in izdelovalec Imetnik dovoljenja za promet z zdravilom
The pharmacokinetics of NovoMix 50 have not been investigated in paediatrics, elderly patients or in patients with renal or hepatic impairment. 
Posebne skupine bolnikov Farmakokinetika zdravila NovoMix 50 ni raziskana pri otrocih, starejših bolnikih in bolnikih z okvaro ledvic ali jeter.
Instruction on how to use NovoMix 70 suspension for injection in FlexPen. 
Navodila za uporabo zdravila NovoMix 70 suspenzija za injiciranje v injekcijskem peresniku FlexPen
1 cartridge contains 3 ml equivalent to 300 units. 
En vložek vsebuje 3 ml, kar ustreza 300 enotam.
10 x 3 ml cartridges 
10 x 3 ml vložki
► Needles and NovoMix 70 FlexPen must not be shared. 
► Igel in zdravila NovoMix 70 FlexPen si ne delite z drugimi.
NovoMix 70 is presented as a suspension for injection in a pre-filled pen. 
Zdravilo NovoMix 70 je na voljo v obliki suspenzije za injiciranje v napolnjenem injekcijskem peresniku.
NovoMix 70 FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist needles. 
Zdravilo NovoMix 70 FlexPen je napolnjen injekcijski peresnik (barvno označen), namenjen za uporabo z iglami NovoFine ali NovoTwist.
► Do not refill the cartridge. 
► Vložkov ne smete znova polniti.
Store below 30°C Do not freeze 
Shranjujte pri temperaturi do 30 °C.
Detailed information on this medicine is available on the website of the European Medicines Agency: http://www.ema.europa.eu. 
http://www.ema.europa.eu.
NovoMix 70 is administered subcutaneously by injection in the thigh or in the abdominal wall. 
Zdravilo NovoMix 70 se z injekcijo aplicira subkutano v stegno ali trebušno steno.
NovoMix 70 is a biphasic suspension of the insulin analogue, insulin aspart. 
Zdravilo NovoMix 70 je dvofazna suspenzija insulinskega analoga, insulina aspart.
NovoMix 70 is a mixture consisting of 70% soluble insulin aspart and 30% insulin aspart crystallised with protamine. 
Zdravilo NovoMix 70 je mešanica, ki vsebuje 70 % topnega insulina aspart in 30 % insulina aspart, kristaliziranega s protaminom.
► Needles and NovoMix 50 FlexPen must not be shared. 
► Igel in zdravila NovoMix 50 FlexPen si ne delite z drugimi.
► If you exercise more than usual or if you want to change your usual diet, as this may affect your blood sugar level. 
Posvetujte se z zdravnikom: ► če imate težave z ledvicami ali jetri, nadledvično žlezo, hipofizo ali ščitnico, ► če ste telesno bolj dejavni kot ponavadi ali želite spremeniti svojo običajno prehrano, kajti to lahko vpliva na koncentracijo vašega krvnega sladkorja,
5 x 3 ml cartridges 
5 x 3 ml vložki
NovoMix 50 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid-acting and intermediate-acting insulin aspart in the ratio 50/50. 
Kako ravnati z injekcijskim peresnikom NovoMix 50 FlexPen Injekcijski peresnik NovoMix 50 FlexPen je napolnjen, barvno kodiran injekcijski peresnik za enkratno uporabo, ki vsebuje mešanico hitrodelujočega in srednjedolgodelujočega insulina aspart v razmerju 50/50.
► After each injection, be sure to remove and discard the needle and store NovoMix 50 without the needle attached. 
► Po vsakem injiciranju morate iglo odstraniti in zavreči, zdravilo NovoMix 50 pa shraniti brez nameščene igle.
NovoMix 50 FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist needles. 
Zdravilo NovoMix 50 FlexPen je napolnjen injekcijski peresnik (barvno označen), namenjen za uporabo z iglami NovoFine ali NovoTwist.
NovoMix 30 is for injection under the skin (subcutaneously). 
Zdravilo NovoMix 30 je namenjeno injiciranju pod kožo (subkutani uporabi).
A 16-week clinical trial comparing postprandial glycaemic control of meal-related NovoMix 30 with meal-related human insulin/biphasic human insulin 30 and bedtime NPH insulin was performed in 167 patients aged 10 to 18 years. 
V njem so primerjali urejenost postprandialne glikemije med uporabo zdravila NovoMix 30 ob obrokih in uporabo humanega insulina/bifaznega humanega insulina 30 ob obrokih ter NPH insulina pred spanjem.
Instruction on how to use NovoMix 50 suspension for injection in FlexPen. 
Navodila za uporabo zdravila NovoMix 50 suspenzija za injiciranje v injekcijskem peresniku FlexPen
NovoMix 50 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 50 is essentially ‘sodium-free'. 
Zdravilo NovoMix 50 vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
NovoMix 70 is a biphasic suspension of 70% soluble insulin aspart (rapid-acting human insulin analogue) and 30% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue). 
Zdravilo NovoMix 70 je dvofazna suspenzija, s 70 % topnega insulina aspart (hitrodelujočega analoga humanega insulina) in 30 % s protaminom kristaliziranega insulina aspart (srednjedolgodelujočega analoga humanega insulina).
NovoMix 30 FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist needles. 
Zdravilo NovoMix 30 FlexPen je napolnjen injekcijski peresnik (barvno označen), namenjen za uporabo z iglami NovoFine ali NovoTwist.
NovoMix 50 is a biphasic suspension of the insulin analogue, insulin aspart. 
Zdravilo NovoMix 50 je dvofazna suspenzija insulinskega analoga, insulina aspart.
NovoMix 50 is administered subcutaneously by injection in the thigh or in the abdominal wall. 
Zdravilo NovoMix 50 se z injekcijo aplicira subkutano v stegno ali trebušno steno.